RNU6-798P

Across TCGA pan-cancer cohorts, RNU6-798P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-798P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-798P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-798P expression acts as an unfavorable survival marker.

KIRP, BRCA, and STAD are the cancer types where RNU6-798P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.132	0.772	<.001	72	view →
BRCA	OS	Tertile	III,IV	0.233	0.833	<.001	48	view →
STAD	OS	Tertile	II,III,IV	0.275	0.720	.002	27	view →
LAML	DFS	Tertile	All	0.253	0.600	.016	18	view →
UCEC	DFS	Tertile	II,III,IV	0.100	0.511	.046	18	view →
HNSC	DFS	Tertile	All	0.084	0.660	<.001	9	view →
KIRC	OS	Tertile	All	0.337	0.663	.009	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-798P–KIRP (OS)

Open the KIRP breakdown →